WordNet

in this circumstance or respect or on this point or detail; "what do we have here?"; "here I must disagree"
the present location; this place; "where do we go from here?"
to this place (especially toward the speaker); "come here, please" (同)hither
at this time; now; "well adjourn here for lunch and discuss the remaining issues this afternoon"
being here now; "is everyone here?"
in or at this place; where the speaker or writer is; "I work here"; "turn here"; "radio waves received here on Earth"
relating to or having the characteristics of a family; "children of the same familial background"; "familial aggregation"
occurring among members of a family usually by heredity; "an inherited disease"; "familial traits"; "genetically transmitted features" (同)genetic, hereditary, inherited, transmitted, transmissible

PrepTutorEJDIC

《場所・位置》『ここで(に)』,ここへ,(図などを指して)この場所に(へ),この地点で(に) / 《関連》『この点で』,このあたりで;『この場合』,この時 / 《文頭において,相手の注意を話者のほうに引き付ける》ほら(さあ),ここに / この世で,現世で / 《名詞の後に用いて》ここの,ここにいる(ある) / 《前置詞の後で》『ここ』,この場所 / 『さあ』,ほら,おい
家族の,家族特有の / 違伝的な,血統にあらわれる
《選択を表し,語句・節を結んで》《肯定文・疑問文で》・・・『または』・・・,・・・か・・・ / 《否定文で》・・・も・・・もない / 《命令的表現の後で》『さもないと』 / 《前出の語を言い換えたり説明したりして》『すなわち』,言い換えれば
世襲の,親譲りの / 遺伝的な,遺伝性の
Oregon

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 糖尿病性腎症の概要 overview of diabetic nephropathy
2. IgA腎症の治療および予後 treatment and prognosis of iga nephropathy
3. 小児における常染色体劣性多発性嚢胞腎 autosomal recessive polycystic kidney disease in children
4. 新規に特定された慢性腎臓病を有する患者に対する診断的アプローチ diagnostic approach to the patient with newly identified chronic kidney disease
5. 常染色体優性尿細管間質性腎臓病（髄質嚢胞性腎疾患） autosomal dominant tubulointerstitial kidney disease medullary cystic kidney disease

Searching the co-occurrence of pathogenic mutations for Leber's hereditary optic neuropathy and hearing loss in more than 26,000 whole mitochondrial genomes.

Yang H1, Liu R2, Wang CC2.
Mitochondrial DNA. Part A. DNA mapping, sequencing, and analysis.Mitochondrial DNA A DNA MappSeq Anal.2016 Sep;27(5):3399-402. doi: 10.3109/19401736.2015.1018239. Epub 2015 Feb 25.
The co-occurrence of pathogenic or candidate mutations for Leber's hereditary optic neuropathy (LHON) and hearing loss has long been suggested to be a rare incident. The "rare" is probably caused by inadequate database searches. In this study, we created and released a comprehensive database with de
PMID 25714144

Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.

Ichimura K1, Kikuchi H2, Imayoshi S2, Dias MS2.
Auris, nasus, larynx.Auris Nasus Larynx.2016 Aug;43(4):429-32. doi: 10.1016/j.anl.2015.12.001. Epub 2015 Dec 29.
OBJECTIVE: Hereditary hemorrhagic telangiectasia (HHT) is widely known to cause bleeding that is difficult to control because of the associated vascular wall fragility. Although nasal dermoplasty results in decreased severity and frequency of nasal bleeding in patients with HHT, it does not eradicat
PMID 26739947

Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?

Lener MR1, Scott RJ2, Kluźniak W1, Baszuk P1, Cybulski C1, Wiechowska-Kozłowska A3, Huzarski T1, Byrski T1, Kładny J4, Pietrzak S1, Soluch A1, Jakubowska A1, Lubiński J1.
International journal of cancer.Int J Cancer.2016 Aug 1;139(3):601-6. doi: 10.1002/ijc.30116. Epub 2016 Apr 18.
Understanding of the etiology and risk of pancreatic cancer (PaCa) is still poorly understood. This study evaluated the prevalence of 10 Polish founder mutations in four genes among PaCa patients and assessed their possible association with the risk of disease in Poland. In the study 383 PaCa patien
PMID 27038244